Casdin Capital as of Sept. 30, 2023
Portfolio Holdings for Casdin Capital
Casdin Capital holds 38 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sarepta Therapeutics (SRPT) | 13.6 | $123M | 1.0M | 121.22 | |
| Biolife Solutions Com New (BLFS) | 11.9 | $107M | 7.8M | 13.81 | |
| Eqrx | 9.7 | $88M | 40M | 2.22 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 6.9 | $62M | 1.3M | 49.24 | |
| Relay Therapeutics (RLAY) | 6.4 | $58M | 6.9M | 8.41 | |
| Revolution Medicines (RVMD) | 5.5 | $50M | 1.8M | 27.68 | |
| Verve Therapeutics (VERV) | 4.3 | $39M | 3.0M | 13.26 | |
| Alnylam Pharmaceuticals (ALNY) | 4.3 | $39M | 220k | 177.10 | |
| Intellia Therapeutics (NTLA) | 4.1 | $37M | 1.2M | 31.62 | |
| EXACT Sciences Corporation (EXAS) | 3.5 | $31M | 460k | 68.22 | |
| Somalogic Class A Com | 3.3 | $30M | 13M | 2.39 | |
| Pliant Therapeutics (PLRX) | 3.0 | $27M | 1.6M | 17.34 | |
| Denali Therapeutics (DNLI) | 3.0 | $27M | 1.3M | 20.63 | |
| Mirati Therapeutics | 2.4 | $22M | 498k | 43.56 | |
| Blueprint Medicines (BPMC) | 2.1 | $19M | 371k | 50.22 | |
| Tenaya Therapeutics (TNYA) | 1.8 | $16M | 6.4M | 2.55 | |
| Tango Therapeutics (TNGX) | 1.6 | $15M | 1.3M | 11.26 | |
| Beam Therapeutics (BEAM) | 1.5 | $14M | 570k | 24.05 | |
| 4d Molecular Therapeutics In (FDMT) | 1.5 | $13M | 1.0M | 12.73 | |
| Genedx Holdings Corp Com Cl A (WGS) | 1.2 | $11M | 3.1M | 3.64 | |
| Abcellera Biologics (ABCL) | 1.2 | $11M | 2.4M | 4.60 | |
| Pacific Biosciences of California (PACB) | 1.0 | $8.6M | 1.0M | 8.35 | |
| Avidity Biosciences Ord (RNA) | 0.9 | $8.0M | 1.3M | 6.38 | |
| 2seventy Bio Common Stock | 0.9 | $7.9M | 2.0M | 3.92 | |
| Illumina Call Option (ILMN) | 0.8 | $6.9M | 50k | 137.28 | |
| Century Therapeutics (IPSC) | 0.7 | $6.4M | 3.2M | 2.00 | |
| Maxcyte (MXCT) | 0.7 | $5.9M | 1.9M | 3.12 | |
| Fate Therapeutics (FATE) | 0.5 | $4.3M | 2.1M | 2.12 | |
| Prime Medicine (PRME) | 0.4 | $3.5M | 367k | 9.54 | |
| D Fluidigm Corp Del (LAB) | 0.4 | $3.5M | 1.2M | 2.90 | |
| Sana Biotechnology (SANA) | 0.3 | $2.9M | 750k | 3.87 | |
| Monte Rosa Therapeutics (GLUE) | 0.3 | $2.4M | 511k | 4.79 | |
| Absci Corp (ABSI) | 0.1 | $1.3M | 973k | 1.32 | |
| Exscientia Ads (EXAI) | 0.1 | $967k | 214k | 4.52 | |
| Codexis (CDXS) | 0.1 | $567k | 300k | 1.89 | |
| Singular Genomics Systems In | 0.1 | $504k | 1.3M | 0.38 | |
| Lianbio Sponsored Ads (LIANY) | 0.0 | $308k | 206k | 1.49 | |
| Kronos Bio | 0.0 | $161k | 124k | 1.30 |
